- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Hansa Biopharma AB (HNSAs)
Hansa Biopharma AB stock price live, this page displays ST HNSA stock exchange data. View the HNSA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Hansa Biopharma AB real time stock price chart below.
What Is the Hansa Biopharma AB Stock Price Today?
The Hansa Biopharma AB stock price today is 24.11.
What Is the Stock Symbol for Hansa Biopharma AB?
The stock symbol for Hansa Biopharma AB is ""HNSA.""
What Stock Exchange Does Hansa Biopharma AB Trade On?
Hansa Biopharma AB is listed and trades on the Stockholm stock exchange.
Is Hansa Biopharma AB a Good Stock to Buy?
Determining whether Hansa Biopharma AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the HNSA quote. (ISIN: SE0002148817)
What Is the Hansa Biopharma AB Stock Price Today?
The Hansa Biopharma AB stock price today is 24.11.
What Is the Stock Symbol for Hansa Biopharma AB?
The stock symbol for Hansa Biopharma AB is ""HNSA.""
What Stock Exchange Does Hansa Biopharma AB Trade On?
Hansa Biopharma AB is listed and trades on the Stockholm stock exchange.
Is Hansa Biopharma AB a Good Stock to Buy?
Determining whether Hansa Biopharma AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the HNSA quote. (ISIN: SE0002148817)
24.11
0.00(0.00%)
Closed·
Fair Value
An estimate of a Hansa Biopharma AB's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
24.10
24.11
52 wk Range
24.04
38.37
HNSAs Scorecard
Full Analysis
2 analysts have revised their earnings upwards for the upcoming period
HNSAs is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a Hansa Biopharma AB's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
24.1024.11
52 wk Range
24.0438.37
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
HNSAs Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Hansa Biopharma AB's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell
Hansa Biopharma AB Company Profile
Hansa Biopharma AB (publ), a biopharmaceutical company, engages in development and commercialization of treatments for patients with rare immunological conditions in Sweden, North America, and rest of Europe. The company offers Idefirix(imlifidase), which targets and cleaves all classes of immunoglobulin G (IgG) antibodies for the desensitization treatment of sensitized adult kidney transplant patients with a positive crossmatch test. It is also developing HNSA-5487, a next generation IgG-cleaving enzyme to address acute and chronic neuro-autoimmune conditions, including myasthenia gravis. In addition, the company evaluates imlifidase in three therapy areas, including autoimmune, gene therapy, and transplantation. It has a collaboration agreement with Sarepta Therapeutics to assess imlifidase as a pre-treatment in limb-girdle muscular dystrophy (LGMD) and duchenne muscular dystrophy (DMD); AskBio to evaluate imlifidase as a pre-treatment in pompe disease; and research and development collaboration agreement with Genethon to evaluate the safety and efficacy of imlifidase as pre-treatment to gene therapy in Crigler-Najjar syndrome patients with anti-AAV antibodies. Hansa Biopharma AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.
Compare HNSAs to Peers and Sector
Metrics to compare | HNSAs | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipHNSAsPeersSector | |
|---|---|---|---|---|
P/E Ratio | −3.7x | −8.9x | −0.5x | |
PEG Ratio | −0.09 | −0.19 | 0.00 | |
Price/Book | −5.0x | 6.1x | 2.6x | |
Price / LTM Sales | 11.2x | 39.3x | 3.2x | |
Upside (Analyst Target) | - | 16.9% | 42.7% | |
Fair Value Upside | Unlock | 2.1% | 5.8% | Unlock |
Earnings
Latest Release
Jul 17, 2025
EPS / Forecast
-2.53 / -1.66
Revenue / Forecast
49.10M / 59.05M
FAQ
What Stock Exchange Does Hansa Biopharma AB Trade On?
Hansa Biopharma AB is listed and trades on the BATS Europe stock exchange.
What Is the Stock Symbol for Hansa Biopharma AB?
The stock symbol for Hansa Biopharma AB is "HNSAs."
What Is the Hansa Biopharma AB Market Cap?
As of today, Hansa Biopharma AB market cap is 2.19B.
What Is Hansa Biopharma AB's Earnings Per Share (TTM)?
The Hansa Biopharma AB EPS (TTM) is -8.72.
When Is the Next Hansa Biopharma AB Earnings Date?
Hansa Biopharma AB will release its next earnings report on 22 Oct 2025.
From a Technical Analysis Perspective, Is HNSAs a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Hansa Biopharma AB Stock Split?
Hansa Biopharma AB has split 0 times.
How Many Employees Does Hansa Biopharma AB Have?
Hansa Biopharma AB has 140 employees.
What is the current trading status of Hansa Biopharma AB (HNSAs)?
As of 23 Jul 2025, Hansa Biopharma AB (HNSAs) is trading at a price of 24.11, with a previous close of 24.11. The stock has fluctuated within a day range of 24.10 to 24.11, while its 52-week range spans from 24.04 to 38.37.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.